A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases.
Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, Gopal R, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L, Bloom ES, Chun SG.
Garg AK, et al. Among authors: philip nv.
JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad093. doi: 10.1093/jncics/pkad093.
JNCI Cancer Spectr. 2023.
PMID: 37944053
Free PMC article.
Clinical Trial.